| Descriptor English: | von Hippel-Lindau Disease | ||||||
| Descriptor Spanish: |
Enfermedad de von Hippel-Lindau
| ||||||
| Descriptor Portuguese: | Doença de von Hippel-Lindau | ||||||
| Descriptor French: | Maladie de von Hippel-Lindau | ||||||
| Entry term(s): |
Angiomatoses, Familial Cerebello-Retinal Angiomatoses, Familial Cerebelloretinal Angiomatosis Retinae Angiomatosis, Familial Cerebello-Retinal Angiomatosis, Familial Cerebelloretinal Cerebello-Retinal Angiomatoses, Familial Cerebello-Retinal Angiomatosis, Familial Cerebelloretinal Angiomatoses, Familial Cerebelloretinal Angiomatosis, Familial Familial Cerebello Retinal Angiomatosis Familial Cerebello-Retinal Angiomatoses Familial Cerebello-Retinal Angiomatosis Familial Cerebelloretinal Angiomatoses Familial Cerebelloretinal Angiomatosis Hippel Lindau Disease Hippel-Lindau Disease Lindau Disease Lindau's Disease Lindau's Diseases Lindaus Disease VHL Syndrome VHL Syndromes von Hippel Lindau Disease von Hippel Lindau Syndrome von Hippel-Lindau Syndrome |
||||||
| Tree number(s): |
C10.562.925 C14.907.077.925 C16.131.077.245.750 C16.320.184.750 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D006623 | ||||||
| Scope note: | An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions. |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Public MeSH Note: | 2008; see HIPPEL-LINDAU DISEASE 1991-2007; see ANGIOMATOSIS 1975-1990 |
||||||
| History Note: | 2008 (1975) |
||||||
| Entry Version: | VON HIPPEL LINDAU DIS |
||||||
| DeCS ID: | 6781 | ||||||
| Unique ID: | D006623 | ||||||
| NLM Classification: | QS 677 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1999/01/01 | ||||||
| Revision Date: | 2017/12/14 |
|
|
von Hippel-Lindau Disease
- Preferred
| Concept UI |
M0010373 |
| Scope note | An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions. |
| Preferred term | von Hippel-Lindau Disease |
| Entry term(s) |
Angiomatoses, Familial Cerebello-Retinal Angiomatoses, Familial Cerebelloretinal Angiomatosis Retinae Angiomatosis, Familial Cerebello-Retinal Angiomatosis, Familial Cerebelloretinal Cerebello-Retinal Angiomatoses, Familial Cerebello-Retinal Angiomatosis, Familial Cerebelloretinal Angiomatoses, Familial Cerebelloretinal Angiomatosis, Familial Familial Cerebello Retinal Angiomatosis Familial Cerebello-Retinal Angiomatoses Familial Cerebello-Retinal Angiomatosis Familial Cerebelloretinal Angiomatoses Familial Cerebelloretinal Angiomatosis Hippel Lindau Disease Hippel-Lindau Disease Lindau Disease Lindau's Disease Lindau's Diseases Lindaus Disease VHL Syndrome VHL Syndromes von Hippel Lindau Disease von Hippel Lindau Syndrome von Hippel-Lindau Syndrome |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
